No Data
No Data
No Data
No Data
No Data
Seer, Inc. (NASDAQ:SEER) Is a Favorite Amongst Institutional Investors Who Own 51%
Yahoo FinanceApr 12 18:13
Candel Therapeutics Receives FDA Orphan Drug Designation for Its Pancreatic Cancer Treatment
Seeking AlphaApr 11 21:18
Seer Inc(SEER.US) Officer Sells US$107.42K in Common Stocks
$Seer Inc(SEER.US)$ Officer Farokhzad Omid sold 52,857 shares of Common Stocks on Mar 7, 2024 at an average price of $2.0323 for a total value of $107.42K.Source: Announcement What is statement of cha
Futu NewsMar 13 07:12
Seer Price Target Announced at $7.00/Share by Morgan Stanley
Seer Price Target Announced at $7.00/Share by Morgan Stanley
Dow JonesMar 5 23:51
Morgan Stanley Reinstates Equal-Weight on Seer, Announces $7 Price Target
Morgan Stanley analyst Yuko Oku reinstates Seer with a Equal-Weight and announces $7 price target.
Analyst UpgradesMar 5 23:41
Seer Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 257.14% Morgan Stanley → $7 Reinstates → Equal-Weight 02/21/2023 410.2% Morgan Stanley $11 → $1
BenzingaMar 5 23:38
No Data
No Data